insulin drugs glp 1 receptor agonist market GLP-1 Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 GLP-1 Agonists Market Report 2025-2033,

Discover GLP-1 weight loss drugs in India (2026)

Ozempic (semaglutide) is a medication used to manage type 2 diabetes

Metseras pipeline includes MET-097i, a GLP-1 receptor agonist designed for once-monthly dosing, and MET-233i, an amylin analog being developed for monthly administration

Wear up to 8 hours, then remove and toss

For professionals in pharma, clinical research, and regulatory affairs, this space is evolving fastand full of opportunity

Their findings suggest that patients may be able to continue taking the medications prior to their surgeries without a high risk of aspiration.As more patients begin taking medications to help manage blood sugar l